Editorial Policy
Preprints
The Journal of Bone Marrow Transplantation and Cellular Therapy recommends that authors deposit manuscripts as preprints to accelerate the circulation of article data before peer review. A preprint is a manuscript ready for submission to a journal and deposited on reliable servers before or in parallel with submission to a journal. Preprints are optional for authors, and it is assumed that, when submitting the manuscript, the name of the preprint server and the respective DOI are provided in the submission system. Articles submitted as preprints share with journals the originality of publication. The Journal of Bone Marrow Transplantation and Cellular Therapy recommends preprint repositories, such as BioRXiv, EmeRI and SciELO Preprints.
However, the content of the material sent for evaluation cannot have been previously published or simultaneously submitted to other journals.
Peer Review Process
The evaluation process of Journal of Bone Marrow Transplantation and Cellular Therapy follows the principles of double-anonymized peer review. The editorial secretary evaluates manuscripts regarding their scope and compliance with submission standards, originality, relevance and technical quality. If they do not meet these requirements, they will be rejected or sent back to the authors for adjustment.
The Journal of Bone Marrow Transplantation and Cellular Therapy uses the Similarity Check/iThenticate system for evaluate similarities in content (plagiarism) with other texts available on the web. The Journal of Bone Marrow Transplantation and Cellular Therapy follows the guidelines of the Code of Conduct and Best Practice Guidelines for Journal Editors from COPE for any concern about plagiarism.
Articles will be selected based on originality, quality and scientific merit. At least two researchers with recognized experience in the subject will review each manuscript. They may recommend approval as presented, request minor or major revisions, or reject the manuscript. Reviewers must not have conflicts of interest and must be committed to fair judgment. Their conclusions must be objective, pointing out relevant articles that have not been cited. Reviewers must also treat articles confidentially. The identity of reviewers is hidden from the authors.
A conflict of interest is defined when an author (or the institution with which the author is affiliated), reviewer, or editor has financial or personal relationships that could influence their actions. However, not all relationships represent an actual conflict of interest; it depends on whether the individual believes the relationship affects their ability to make unbiased scientific judgments. Financial relationships, such as employment, consulting, stock ownership, and paid expert testimony, are the most easily identifiable conflicts of interest. Conflicts of interest can arise for other reasons, such as personal relationships, academic competition, and intellectual passion.
Manuscripts that require revision will be sent to the author, who must submit a new version and a letter to the editor, in which they must comment on each reviewer's recommendations. Additional and/or changed paragraphs should be highlighted in the text. If the author disagrees with the reviewer's suggestions, they must explain the reasons. After verifying that the new version adheres to the recommendations, the editor must make the final decision or forward the manuscript for another round of evaluation if the changes have not been sufficiently addressed.
The entire process is available to authors anytime through the journal's online management system. The deadline for returning the corrected version by the author is 30 days for each round. If the correction deadline is not met, the process will be automatically canceled, and the manuscript will be archived. In cases where there are conflicting recommendations among the reviewers, it will be necessary to request a third review.
The Editor is responsible for the final decision on the acceptance or rejection of the articles, and his name is published in the article's final version.
The opinions expressed in the articles are the sole responsibility of their authors. The Journal of Bone Marrow Transplantation and Cellular Therapy reserves the right to make minor adjustments to maintain the uniformity of the publication, provided that they are communicated to and approved by the authors.
Open Data
The Journal of Bone Marrow Transplantation and Cellular Therapy recommends that authors, whenever applicable, deposit and share the data, codes and/or methods used in the production of the manuscript, with the responsible author being responsible for informing, during the submission process, the chosen repository, enabling access to reviewers and editors, unless this is not possible for ethical, privacy or confidentiality reasons. To ensure complete transparency of the data obtained, the Journal of Bone Marrow Transplantation and Cellular Therapy requires authors to declare that these are available upon request if data are not made available in public repositories, and authors must state why these data are not publicly available in such cases. It should be noted that data sharing does not apply to the article if no dataset was generated or analyzed during the study. Research data includes, but is not limited to, raw data, processed data, spreadsheets, statistics, laboratory notebooks, field notebooks, questionnaires, photographs, methodologies, standards, and protocols. Authors may use their institution's data repository or choose from the repositories recommended at re3data.org . Other options are Dryad, Figshare, Zenodo, Mendeley Data, OSF.
Fees
The Journal of Bone Marrow Transplantation and Cellular Therapy does not charge submission or processing fees.
Ethics and Misconduct, Correction and Retraction Policy
The Journal of Bone Marrow Transplantation and Cellular Therapy guides authors, editors, and reviewers on ethical and responsible behavior:
Authors: By submitting manuscripts, authors undertake to respect scientific integrity practices, strictly observe the criteria for attribution of authorship and report the individual contributions of each author. They must also declare all potential conflicts of interest concerning the submitted article and provide information on previous publications, presentation of the work, academic affiliations, and funding sources. Authors must undertake to cite and provide correct references to all articles, data, and other documents mentioned in the article. The submitting author assumes, on behalf of all authors of the manuscript, responsibility for the integrity of the research and the manuscript's content, as well as for making corrections or retractions, if necessary. Whenever applicable, certificates from the ethics committees that approve the research must be presented at the time of submission.
Editors: Editors undertake to adopt and ensure editorial neutrality and impartiality and to ensure that published manuscripts comply with internationally established ethical recommendations. They must verify that the research has been approved by ethics committees, requiring certificates if these have not been presented. When assigned to manage the manuscript evaluation process, editors must take measures to identify and prevent the publication of papers that present research misconduct. They also deal appropriately with formal allegations of scientific misconduct and continually improve the journal and its content, including the publication of corrections, retractions, clarifications, and apologies whenever necessary. Editors must declare potential conflicts of interest in evaluating manuscripts and act to prevent those involving authors and reviewers that may compromise the ethical standards of the publication. The editor's name, responsible for managing the evaluation process, will be published in the approved articles in PDF format.
Reviewers: When appointed, only those who are able and available to prepare the review with the most extraordinary scientific rigor within the defined deadline and who do not have any conflicts of interest that could influence their evaluation or recommendation should accept the invitation to review. Reviewers who participate in the evaluation process evaluate the work under the best academic and scientific integrity practices and point out any instances of scientific misconduct when identified. They also undertake to maintain the confidentiality of the documents they receive and of the process during the evaluation. Journal of Bone Marrow Transplantation and Cellular Therapy employs a double-anonymized evaluation system whereby reviewers and authors’ names are not identified.
Published articles that contain seriously flawed data, such that their findings and conclusions cannot be trusted, may be retracted to correct the scientific record. After a discussion with the corresponding author, the author may request additions, corrections, and retractions or initiate them by the editor-in-chief. Readers who identify material errors in third-party work should contact the corresponding author of the respective paper directly. All additions, corrections, and retractions are subject to approval by the Editors-in-Chief. Minor corrections and additions, however, will not be published. The corresponding author must obtain approval from all co-authors before requesting/submitting additions, corrections, and retractions or provide evidence that such approval was requested. The originally published article will remain on the web, except in extraordinary circumstances.
Suppose plagiarism may be detected in a published article after an internal investigation. In that case, a letter will be sent immediately to all authors, their affiliated institutions, and funding agencies, if applicable, and the article will subsequently be retracted.
Policy on Conflicts of Interest
Conflicts of interest can be personal, commercial, political, academic, or financial. Conflicts of interest can occur when authors, reviewers, or editors have interests that may influence the preparation or evaluation of manuscripts. When submitting a manuscript, authors are responsible for acknowledging and disclosing financial or other conflicts that may have influenced the work. If there is, even potentially, a conflict of interest, the author(s) must disclose it in a signed document attached to the submission platform. For more information, see Disclosure of Financial and Non-Financial Relationships, Activities, and Conflicts of Interest.
Potential conflicts of interest include employment, consultancy, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors may disclose any conflicts or declare their absence, which will be published if the article is accepted. Detailed disclosures will be included in the journal records.
For the Journal of Bone Marrow Transplantation and Cellular Therapy, the following relationships between editors and authors are considered conflicts and should be avoided: current colleagues, recent colleagues, recent co-authors, and master’s and doctoral students for whom the editor served as committee chair. After the assignment of articles, individual editors must inform the editor-in-chief of any conflicts not included here. If none of the editors pass all the conflict tests, the co-editors with the fewest conflicts will be assigned to the manuscript. Additionally, the least conflicting co-editors are assigned to all articles submitted for review by the handling editors. Submissions to the journal are also assigned to reviewers to minimize conflicts of interest. After the articles are assigned, reviewers are asked to inform the editor of any potential conflicts.
Adoption of similarity software
The Journal of Bone Marrow Transplantation and Cellular Therapy, uses the Similarity Check/iThenticate system to evaluate the content of all submitted manuscripts. Articles that show significant percentages of similarity with other texts on the web will be automatically rejected. The Journal of Bone Marrow Transplantation and Cellular Therapy, aims to publish high-quality original research. Submission of a manuscript to this journal indicates that the study has not been published or submitted to another scientific publication.
Adoption of software using Artificial Intelligence resources
Hiding the use of AI tools is an ethical failure that violates the transparency of scientific publishing. Therefore, the Journal of Bone Marrow Transplantation and Cellular Therapy establishes the following recommendations for the actors involved in the process:
Authors: Authorship entails responsibilities and tasks that can only be assigned to and performed by human beings. The Journal of Bone Marrow Transplantation and Cellular Therapy tolerates the use of AI by authors to improve the clarity and language of the work. The application of technology must be done with human supervision and control, and authors must carefully review and edit the results. Authors must disclose the use of AI and AI-assisted technologies in a statement that will be included in the published article. Authors must not list AI and AI-assisted technologies as authors or co-authors nor cite them in the text. The Journal of Bone Marrow Transplantation and Cellular Therapy does not permit using generative AI or AI-assisted tools to create or alter images in submitted manuscripts unless AI or AI-assisted tools are part of the research design or research methods. In this case, the use should be described in the Methods section. Authors must report the use of generative AI and AI-assisted technologies in the writing of the manuscript by means of a statement inserted at the end of the main text. This declaration does not apply to the use of basic tools for checking grammar, spelling, references, etc. If there is nothing to declare, it is not necessary to include the declaration.
Editors: Editors are called upon to address the effects of AI use and content on publication when employed/used to perform or generate analytical work or report results. Editors must be prepared and supported to conduct scientific scrutiny and ensure the quality and integrity of published scientific papers. In particular, editors are responsible for avoiding misinformation that could lead to adverse consequences and potential harm to individuals. At the same time, editors must adhere to established ethical and editorial standards and best practices, including documenting any assistance from AI tools or resources during the reception, review, and editing processes. When the manuscript received is not a preprint, the editor should not submit the manuscript to services, which could cause the identities and content to leak. Upon detecting any ethical flaws in the manuscript, the editor should follow the editorial office's ethical standards of good practices.
Reviewers: When the manuscript received is not a preprint, the reviewer should not submit the manuscript to services that may cause the leaking of identities and content. Like editors, reviewers are called upon to address the effects of AI use and content on the publication when employed/used to perform or generate analytical work or to report the results (which are expected to be indicated by the author in the Abstract and Methods). In particular, reviewers are called upon to avoid misinformation that may lead to adverse consequences and potential harm to people. AI applications and content should follow ethical standards and good practices and be documented in the reviews.
Gender and Sex Issues
The editorial team of the Journal of Bone Marrow Transplantation and Cellular Therapy, along with the authors who publish in the journal, follows the guidelines on Sex and Gender Equity in Research (SAGER). The SAGER guidelines comprise a set of guidelines for reporting information on sex and gender in study design, data analysis, and the results and interpretation of findings.
The Journal of Bone Marrow Transplantation and Cellular Therapy, is committed to the principles of Diversity, Equity, Inclusion and Accessibility (DEIA) in its practices, aiming to expand knowledge and improve the human condition.
The Journal of Bone Marrow Transplantation and Cellular Therapy, aims to address systemic inequalities and biases, promote equitable opportunities for authors and foster an inclusive environment for the development of all stakeholders involved in publishing. Thus, it contributes to the advancement of these principles within the scientific community in the field of fisheries science.
Section editors are guided and motivated to:
- Improve diversity in the selection of reviewers;
- Encourage authors to adopt more inclusive citation practices in their decisions;
- Promote inclusive language.
The Editors-in-Chief, mindful of increasing diversity and recognizing the barriers faced in publication by authors, editors, and reviewers belonging to populations historically excluded based on markers such as race, geographic origin, gender, class, sexuality, and disability, among others, always seek to:
- Avoid discrepancies in article acceptance by focusing on increasing the diversity of authors, reviewers, and editors;
- Mitigate both the risk and impact of biases in decision-making during the review;
- Identify alternative processes to interrupt biases;
- Adopt standards for an inclusive culture.
Ethics
The Journal of Bone Marrow Transplantation and Cellular Therapy requires authors to register clinical trials in International Clinical Trials Registry. For clinical trials conducted in Brazil, authors must consult http://www.ensaiosclinicos.gov.br/. Manuscripts describing primary results of unregistered trials will be rejected before peer review. The authors must attach a statement of approval from the institution's Ethics Committee, responsible for approving the research.
When reporting experiments with animals, authors must present the process number approved by the institutional Comitê de Ética para o Uso de Animais (CEUA), following Federal Law No. 11,794/2008 (Arouca Law), which regulates item VII of § 1 of article 225 of the Brazilian Federal Constitution, which establishes procedures for the scientific use of animals. Articles coming from abroad must follow the international standards of the Council for International Organization of Medical Sciences (CIOMS).
When reporting experiments on human subjects, authors should indicate whether the procedures were approved by the institutional Comitê de Ética em Pesquisa (CEP), respecting Resolution No. 466/2012 of the National Health Council (Conselho Nacional de Saúde-CNS). Foreign articles must comply with the 1975 Declaration of Helsinki, revised in 2013. Manuscripts must be accompanied by a statement that the research was conducted with each participant's informed and appropriate consent. For publication of any details or photographs that may identify an individual, written consent is required from that individual or their legal guardian or executor, if applicable. Approval by the CEP is not necessary for research involving interviews, following CNS Resolution No. 510.
Suppose there is any doubt that the research was conducted under current legislation. In that case, the authors must explain their approach and demonstrate that the institutional Ethics Committee expressly approved the study's doubtful aspects. All stages of protocol processing in the CEP/CONEP System occur exclusively through the Plataforma Brasil, which provides specific regulations, including information on ICF/AA.
